TRAM2 and breast carcinoma: Meanwhile, TRAM2-TCNE was detected to be significantly overexpressed in three breast cancer cell lines, MCF-7, T-47D, and BT-474, compared to a non-tumorigenic mammary epithelial cell line, MCF-12A (Figure 3C).